Dexcom (DXCM) Long-Term Deferred Tax (2020 - 2026)
Dexcom (DXCM) posted quarterly Long-Term Deferred Tax of $304.1 million for Q2 2026, down 38.73% year-over-year from $496.3 million in Q2 2025, and up 2.7% quarter-over-quarter from $296.1 million in Q1 2026.
Dexcom (DXCM) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Long-Term Deferred Tax for 7 consecutive years, with $304.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 38.73% year-over-year to $304.1 million; the TTM figure through Jun 2026 stood at $304.1 million (down 38.73% YoY), while the FY2025 annual figure was $295.6 million, down 38.57% from the prior year.
- Long-Term Deferred Tax improved to $304.1 million in Q2 2026 per DXCM's latest filing, from $296.1 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $501.3 million in Q3 2023 and bottomed at $290.8 million in Q1 2022.
- Historically, Long-Term Deferred Tax has averaged $396.1 million across 5 years, with a median of $396.3 million in 2023.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax jumped 58.25% — and 2026, when it slumped 39.24%.
- Dexcom's Long-Term Deferred Tax stood at $341.2 million in 2022, then increased by 22.92% to $419.4 million in 2023, then grew by 14.74% to $481.2 million in 2024, then slumped by 38.57% to $295.6 million in 2025, then gained by 2.88% to $304.1 million in 2026.
- Business Quant data shows DXCM's Long-Term Deferred Tax at $304.1 million in Q2 2026, $296.1 million in Q1 2026, and $295.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 304.10 Mn |
| Mar 31, 2026 | 296.10 Mn |
| Dec 31, 2025 | 295.60 Mn |
| Sep 30, 2025 | 375.60 Mn |
| Jun 30, 2025 | 496.30 Mn |
| Mar 31, 2025 | 487.30 Mn |
| Dec 31, 2024 | 481.20 Mn |
| Sep 30, 2024 | 486.50 Mn |
| Jun 30, 2024 | 475.80 Mn |
| Mar 31, 2024 | 460.70 Mn |
| Dec 31, 2023 | 419.40 Mn |
| Sep 30, 2023 | 501.30 Mn |
| Jun 30, 2023 | 417.00 Mn |
| Mar 31, 2023 | 349.10 Mn |
| Dec 31, 2022 | 341.20 Mn |
| Sep 30, 2022 | 342.30 Mn |
| Jun 30, 2022 | 309.50 Mn |
| Mar 31, 2022 | 290.80 Mn |
| Dec 31, 2021 | 290.50 Mn |
| Sep 30, 2021 | 216.30 Mn |